Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2015

View Archived Issues

Programmable probiotics as urinary diagnostic markers for liver metastases

Encouraging first-in-human data obtained with BI-836826 in CLL

Safety of tesevatinib assessed in a phase Ib trial

Allied-Bristol Life Sciences licenses intellectual property from Harvard

Vical releases topline data from phase I/II study of therapeutic genital herpes vaccine

Guselkumab and ustekinumab do not meet primary endpoint in rheumatoid arthritis trial

Gladius Pharmaceuticals raises funds to develop treatments for multidrug-resistant infections

First patient recruited in phase II study of preterm labor drug OBE-001

Soligenix collaborates with NORD and CLF on pivotal study of SGX-301 for CTCL

Group in Taiwan discloses B-Raf and C-RAF kinase inhibitors

Vertex Pharmaceuticals patents ATR kinase inhibitors

Boehringer Ingelheim patent describes kinase inhibitors

Pfizer opens enrollment in phase III trial of rivipansel in sickle cell disease

Potential new cancer treatments under study at Hangzhou Minsheng

Sanofi presents soluble epoxide hydrolase inhibitors

EMA grants orphan drug designation to AveXis' gene therapy treatment for SMA

CytoDyn to develop PRO-140 for GvHD

Biotest regains rights to tregalizumab after AbbVie opts out of agreement

ELND-005 does not meet primary endpoint in Alzheimer's disease trial

Vaccinex initiates phase II trial of VX-15/2503 in Huntington's disease

RaQualia regains dalbavancin rights in Japan

Agios initiates phase I trial of AG-881 in advanced solid tumors with IDH mutation

FDA clears IND for phase IIa study of T3D-959 in Alzheimer's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...